# GIMAP1

## Overview
GIMAP1, or GTPase, IMAP family member 1, is a gene that encodes a protein belonging to the GTPase family, specifically characterized by the presence of an AIG1 domain, which is involved in guanine nucleotide binding. The GIMAP1 protein plays a pivotal role in the immune system, particularly in the development and survival of lymphocytes, including T and B cells. It is expressed in various immune cells and is crucial for their proper function and survival, especially during the transition between primary and secondary lymphoid stages. The protein is localized in the Golgi complex and is involved in constitutive survival signaling pathways, such as NF-B and PI3-kinase/Akt/mTOR, which are essential for maintaining mature lymphocyte populations. GIMAP1's expression is tightly regulated during immune cell development, and its dysregulation is associated with several autoimmune diseases and cancers, highlighting its clinical significance (Limoges2021The; Saunders2010Putative; Krücken2004Comparative).

## Structure
The GIMAP1 protein is a member of the GTPase family, characterized by a guanine nucleotide-binding domain located in the amino-terminal region. This domain includes conserved motifs typical of GTP-binding proteins, known as the AIG1 domain, which features five G motifs involved in nucleotide binding (Limoges2021The; Krücken2004Comparative). The protein has a molecular mass of 34.4 kDa and consists of 306 amino acids, with a putative transmembrane domain at its COOH-terminus, suggesting a role in membrane anchoring (Limoges2021The; Krücken2004Comparative).

The GIMAP1 protein is expressed in various immune cells, including T and B lymphocytes, and is essential for their survival and function. It is located in the Golgi complex and is expressed during all stages of thymocyte development (Limoges2021The). The protein's expression is upregulated following Th1 differentiation in humans, and its deletion in T cells compromises their survival (Limoges2021The).

While specific details on the secondary, tertiary, and quaternary structures of GIMAP1 are not provided, the presence of a transmembrane domain and the AIG1 domain suggest a complex structure that facilitates its role in immune regulation. The protein's expression and function are influenced by its structural domains, although detailed structural information remains limited.

## Function
GIMAP1 is a member of the GTPase family, playing a crucial role in the development and survival of lymphocytes, particularly B and T cells. It is part of the GIMAP family of proteins, which are involved in regulating lymphocyte development and survival processes. GIMAP1 is essential for the transition between primary and secondary lymphoid stages, significantly affecting mature cell populations in the periphery (Saunders2010Putative). The expression of GIMAP1 is low in early developmental stages but increases sharply in later stages, such as the immature and mature B-cell stages, indicating its importance in B-cell maturation (Saunders2010Putative).

In T cells, GIMAP1 is expressed throughout all stages of development, with its loss significantly affecting the survival capacity of CD4+ single-positive thymocytes from the late thymic stage onward (Saunders2010Putative). The protein is thought to be involved in constitutive survival signaling, potentially through pathways such as NF-B and PI3-kinase/Akt/mTOR, which are critical for lymphocyte survival (Saunders2010Putative). GIMAP1's role in these processes underscores its importance in maintaining mature lymphocyte populations and ensuring proper immune function.

## Clinical Significance
GIMAP1 is implicated in several diseases due to its role in immune cell survival and function. Alterations in GIMAP1 expression have been associated with autoimmune diseases such as systemic lupus erythematosus, Behçet's disease, and type I diabetes. In Behçet's disease, lower expression levels of GIMAP1 in peripheral CD4 T cells have been observed, suggesting a role in T-cell development and selection (Lee2012Genomewide). GIMAP1 is also overexpressed in diffuse large B cell lymphomas (DLBCLs), potentially due to hypomethylation at the Gimap locus, which may contribute to genome rearrangements during B cell lymphomagenesis (Webb2016GIMAP1).

In cancer, GIMAP1 expression is significantly higher in clear cell renal cell carcinoma (ccRCC) tumor tissues compared to normal tissues, indicating its potential as a diagnostic marker and therapeutic target (Zhang2023Prognostic). In lung adenocarcinoma, downregulation of GIMAP1 is linked to poor prognosis, suggesting its role in tumor progression and as a prognostic biomarker (Yuan2020Identification). These findings highlight the clinical significance of GIMAP1 in various diseases, particularly those involving immune dysregulation and cancer.


## References


[1. (Yuan2020Identification) Jingyan Yuan, Bo Yuan, Lizhong Zeng, Boxuan Liu, Yang Chen, Xia Meng, Ruiying Sun, Xin Lv, Wei Wang, and Shuanying Yang. Identification and validation of tumor microenvironment‑related genes of prognostic value in lung adenocarcinoma. Oncology Letters, 20(2):1772–1780, June 2020. URL: http://dx.doi.org/10.3892/ol.2020.11735, doi:10.3892/ol.2020.11735. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ol.2020.11735)

[2. (Lee2012Genomewide) Yun Jong Lee, Yukihiro Horie, Graham R Wallace, Yong Seok Choi, Ji Ah Park, Ji Yong Choi, Ran Song, Young-Mo Kang, Seong Wook Kang, Han Joo Baek, Nobuyoshi Kitaichi, Akira Meguro, Nobuhisa Mizuki, Kenichi Namba, Susumu Ishida, Jinhyun Kim, Edyta Niemczyk, Eun Young Lee, Yeong Wook Song, Shigeaki Ohno, and Eun Bong Lee. Genome-wide association study identifies gimap as a novel susceptibility locus for behçet’s disease. Annals of the Rheumatic Diseases, 72(9):1510–1516, October 2012. URL: http://dx.doi.org/10.1136/annrheumdis-2011-200288, doi:10.1136/annrheumdis-2011-200288. This article has 102 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1136/annrheumdis-2011-200288)

[3. (Limoges2021The) Marc-André Limoges, Maryse Cloutier, Madhuparna Nandi, Subburaj Ilangumaran, and Sheela Ramanathan. The gimap family proteins: an incomplete puzzle. Frontiers in Immunology, May 2021. URL: http://dx.doi.org/10.3389/fimmu.2021.679739, doi:10.3389/fimmu.2021.679739. This article has 33 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2021.679739)

[4. (Saunders2010Putative) Amy Saunders, Louise M. C. Webb, Michelle L. Janas, Amanda Hutchings, John Pascall, Christine Carter, Nicholas Pugh, Geoff Morgan, Martin Turner, and Geoffrey W. Butcher. Putative gtpase gimap1 is critical for the development of mature b and t lymphocytes. Blood, 115(16):3249–3257, April 2010. URL: http://dx.doi.org/10.1182/blood-2009-08-237586, doi:10.1182/blood-2009-08-237586. This article has 47 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1182/blood-2009-08-237586)

[5. (Krücken2004Comparative) Jürgen Krücken, Regina M.U. Schroetel, Inga U. Müller, Nadia Saïdani, Predrag Marinovski, W. Peter M. Benten, Olaf Stamm, and Frank Wunderlich. Comparative analysis of the human gimap gene cluster encoding a novel gtpase family. Gene, 341:291–304, October 2004. URL: http://dx.doi.org/10.1016/j.gene.2004.07.005, doi:10.1016/j.gene.2004.07.005. This article has 97 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.gene.2004.07.005)

[6. (Webb2016GIMAP1) Louise M. C. Webb, Preeta Datta, Sarah E. Bell, Daisuke Kitamura, Martin Turner, and Geoffrey W. Butcher. Gimap1 is essential for the survival of naive and activated b cells in vivo. The Journal of Immunology, 196(1):207–216, January 2016. URL: http://dx.doi.org/10.4049/jimmunol.1501582, doi:10.4049/jimmunol.1501582. This article has 21 citations.](https://doi.org/10.4049/jimmunol.1501582)

[7. (Zhang2023Prognostic) Mengjiao Zhang, Xu Zhang, Jing Hou, Xuemei Liang, and Ming Zhang. Prognostic and immune infiltration signatures of gimap family genes in clear cell renal cell carcinoma. Frontiers in Bioscience-Landmark, 28(11):308, November 2023. URL: http://dx.doi.org/10.31083/j.fbl2811308, doi:10.31083/j.fbl2811308. This article has 1 citations.](https://doi.org/10.31083/j.fbl2811308)